Pulse Biosciences (NASDAQ:PLSE) Stock Crosses Below 50 Day Moving Average of $8.98

Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $8.98 and traded as low as $6.97. Pulse Biosciences shares last traded at $7.22, with a volume of 133,963 shares changing hands.

Pulse Biosciences Stock Performance

The stock’s 50-day moving average price is $8.98 and its 200-day moving average price is $7.96. The company has a market capitalization of $398.69 million, a price-to-earnings ratio of -8.11 and a beta of 1.67.

Institutional Investors Weigh In On Pulse Biosciences

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. LM Advisors LLC acquired a new stake in shares of Pulse Biosciences during the 4th quarter valued at approximately $30,000. Osaic Holdings Inc. lifted its position in shares of Pulse Biosciences by 4.7% during the 2nd quarter. Osaic Holdings Inc. now owns 58,982 shares of the company’s stock valued at $424,000 after acquiring an additional 2,672 shares during the period. Geode Capital Management LLC increased its stake in shares of Pulse Biosciences by 2.1% during the 1st quarter. Geode Capital Management LLC now owns 142,490 shares of the company’s stock worth $479,000 after purchasing an additional 2,933 shares in the last quarter. Nuveen Asset Management LLC increased its stake in shares of Pulse Biosciences by 15.8% during the 4th quarter. Nuveen Asset Management LLC now owns 26,372 shares of the company’s stock worth $323,000 after purchasing an additional 3,607 shares in the last quarter. Finally, BNP Paribas Arbitrage SNC increased its stake in shares of Pulse Biosciences by 713.8% during the 2nd quarter. BNP Paribas Arbitrage SNC now owns 4,199 shares of the company’s stock worth $30,000 after purchasing an additional 3,683 shares in the last quarter. 76.95% of the stock is currently owned by institutional investors and hedge funds.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.